Increased Levels of sRAGE in Diabetic CKD-G5D Patients: A Potential Protective Mechanism against AGE-Related Upregulation of Fibroblast Growth Factor 23 and Inflammation
Advanced glycation end products (AGEs) may induce cardiac remodeling in kidney disease by promoting fibroblast growth factor 23 (FGF-23) expression. Since AGEs are increased in diabetes mellitus (DM), our first aim was to evaluate the existence of any potential association between AGEs, FGF-23, infl...
Saved in:
| Main Authors: | Elena Dozio, Valentina Corradi, Elena Vianello, Elisa Scalzotto, Massimo de Cal, Massimiliano Marco Corsi Romanelli, Claudio Ronco |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2017-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1155/2017/9845175 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of the Soluble Receptor for Advanced Glycation End Products (sRAGE) as a Prognostic Factor for Mortality in Hemodialysis and Peritoneal Dialysis Patients
by: Elena Dozio, et al.
Published: (2018-01-01) -
The Ser82 RAGE Variant Affects Lung Function and Serum RAGE in Smokers and sRAGE Production In Vitro.
by: Suzanne Miller, et al.
Published: (2016-01-01) -
sRAGE as a Prognostic Biomarker in ARDS: Insights from a Clinical Cohort Study
by: Ana Andrijevic, et al.
Published: (2025-01-01) -
Dynamic changes of lung sRAGE in mice with chronic obstructive pulmonary disease induced by cigarette smoke exposure.
by: Yue He, et al.
Published: (2024-01-01) -
Association of sRAGE with Inflammatory Markers and Insulin Resistance across A Spectrum of T2DM Mellitus, Prediabetes, and Healthy Controls
by: Charu Yadav, et al.
Published: (2025-05-01)